This blend combines CJC-1295 without DAC (GRF 1-29), a 29-amino-acid GHRH analogue (MW: 3367.97 g/mol), with Ipamorelin, a selective pentapeptide growth hormone secretagogue (MW: 711.85 g/mol). CJC-1295 no DAC acts on GHRH receptors to stimulate pulsatile GH release, while Ipamorelin activates the ghrelin/GHS receptor without significantly affecting cortisol or prolactin, making the pair a widely used dual-pathway platform for growth hormone axis research.
Specifications
- Quantity: 5mg CJC-1295 (no DAC) + 5mg Ipamorelin
- Form: Lyophilized powder
- Purity: ≥98% HPLC verified
- Storage: -20°C protected from light
- CJC-1295 (no DAC) Molecular Weight: 3367.97 g/mol (29 amino acids)
- Ipamorelin Molecular Weight: 711.85 g/mol (5 amino acids)
Research Applications
- Dual-pathway growth hormone axis studies (GHRH + ghrelin receptor)
- Pulsatile GH secretion pattern investigation
- Receptor selectivity and downstream signaling research
- Body composition and growth factor research models
For in-vitro laboratory and scientific research purposes only. Not for human or animal consumption.
